Advertisement

Ads Placeholder
Loading...

Caris Life Sciences, Inc.

CAI•NASDAQ
Healthcare
Biotechnology
$19.29
$0.16(0.84%)
U.S. Market opens in 27h 44m

Caris Life Sciences, Inc. (CAI) Stock Overview

Explore Caris Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.5B
P/E Ratio-473.70
EPS (TTM)$-3.22
ROE0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$20.60
3 Months$21.60
1 Year Target$21.34

CAI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Caris Life Sciences, Inc. (CAI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $21.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -473.70 and a market capitalization of 5.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.84%
5-Day Change
6.46%
1-Month Change
-0.46%
3-Month Change
-28.50%
6-Month Change
-39.30%
Year-to-Date (YTD) Change
-28.50%
1-Year Change
-31.11%
3-Year Change
-31.11%
5-Year Change
-31.11%
All-Time (Max) Change
-31.11%

Contact Information

https://www.carislifesciences.com
866 771 8946
750 West John Carpenter Freeway, Irving, TX, 75039

Company Facts

17,690 Employees
IPO DateJun 18, 2025
CountryUS
Actively Trading

Frequently Asked Questions